Porton Pharma Solutions Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	793.84	1,131	1,475	1,967	2,850	1,217
Trading Asset Securities	551.89	279.28	-	-	-	-
Cash & Short-Term Investments	1,346	1,411	1,475	1,967	2,850	1,217
Cash Growth	-6.60%	-4.34%	-25.02%	-31.01%	134.24%	-3.90%
Accounts Receivable	872.84	797.47	829.5	690.57	1,506	1,088
Other Receivables	47.67	45.57	36.4	44.99	60.91	66.74
Receivables	920.51	843.05	865.9	735.56	1,567	1,154
Inventory	790.85	770.38	771.31	717.07	902.2	757.39
Other Current Assets	253.32	250.37	129.63	235.13	142.9	82.2
Total Current Assets	3,310	3,274	3,241	3,654	5,463	3,211
Property, Plant & Equipment	3,767	3,879	4,100	4,212	3,381	2,316
Long-Term Investments	293.53	362.8	347.15	388.03	372.65	377.13
Goodwill	288.78	290.46	292.91	291.29	330.11	280.43
Other Intangible Assets	247.03	251.7	258.75	275.16	267.1	130.8
Long-Term Deferred Tax Assets	55.66	51.12	64.19	74.68	62.79	58.92
Long-Term Deferred Charges	392.13	406.5	426.35	430.39	159.66	63.79
Other Long-Term Assets	123.2	34.89	85.4	58.11	108.33	123.54
Total Assets	8,477	8,551	8,816	9,384	10,144	6,562
Accounts Payable	833.16	844.7	899.26	796.14	1,788	1,111
Accrued Expenses	184.71	237.16	183.56	196.32	490.75	210.18
Short-Term Debt	10	10	66.01	20.03	303.35	389.66
Current Portion of Long-Term Debt	-	429.14	329.41	216.01	69.09	95.27
Current Portion of Leases	-	57.85	55.73	45.42	31.08	24.5
Current Income Taxes Payable	-	3.72	10.89	6.17	55.88	34.83
Current Unearned Revenue	148.31	181.4	100.98	57.5	73.63	63.68
Other Current Liabilities	609.67	31.98	59.35	53.81	204.3	189.38
Total Current Liabilities	1,786	1,796	1,705	1,391	3,016	2,119
Long-Term Debt	428.01	481.28	908.98	1,070	312.91	24
Long-Term Leases	514.76	532	595.99	621.38	207.33	207.34
Long-Term Unearned Revenue	175.43	168.7	147.98	109.99	65.25	18.26
Long-Term Deferred Tax Liabilities	89.26	74.82	46.78	91.04	70.52	7.79
Total Liabilities	2,993	3,053	3,405	3,284	3,672	2,376
Common Stock	543.44	543.44	545.46	546.04	546.03	544.4
Additional Paid-In Capital	1,943	1,943	2,041	2,067	1,958	1,799
Retained Earnings	2,867	2,839	2,742	3,293	3,628	1,728
Treasury Stock	-29.87	-29.87	-129.85	-135.27	-133.1	-61.83
Comprehensive Income & Other	34.61	55.27	-0.89	29.24	4.28	-27.3
Total Common Equity	5,358	5,351	5,198	5,801	6,003	3,982
Minority Interest	126.05	147.44	213.2	299.17	469.17	204.53
Shareholders' Equity	5,484	5,498	5,411	6,100	6,472	4,186
Total Liabilities & Equity	8,477	8,551	8,816	9,384	10,144	6,562
Total Debt	952.77	1,510	1,956	1,973	923.77	740.77
Net Cash (Debt)	392.96	-99.74	-481.6	-6.61	1,927	476.1
Net Cash Growth	-	-	-	-	304.68%	-53.09%
Net Cash Per Share	0.69	-0.19	-0.89	-0.01	3.55	0.88
Filing Date Shares Outstanding	557.3	542.18	542.18	546.04	546.03	544.4
Total Common Shares Outstanding	557.3	542.18	542.18	546.04	546.03	544.4
Working Capital	1,525	1,478	1,536	2,263	2,447	1,092
Book Value Per Share	9.61	9.87	9.59	10.62	10.99	7.31
Tangible Book Value	4,822	4,809	4,646	5,234	5,406	3,570
Tangible Book Value Per Share	8.65	8.87	8.57	9.59	9.90	6.56
Buildings	-	1,005	990.29	1,003	800.28	647.71
Machinery	-	3,625	3,545	3,120	2,335	1,820
Construction In Progress	-	475.05	437.4	693.46	1,029	341.58

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.